These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 31855282)

  • 1. Feasibility of imaging
    Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM
    Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioembolization lung shunt estimation based on a
    Kunnen B; van der Velden S; Bastiaannet R; Lam MGEH; Viergever MA; de Jong HWAM
    Med Phys; 2018 Oct; 45(10):4744-4753. PubMed ID: 30179259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.
    Wondergem M; Smits ML; Elschot M; de Jong HW; Verkooijen HM; van den Bosch MA; Nijsen JF; Lam MG
    J Nucl Med; 2013 Aug; 54(8):1294-301. PubMed ID: 23749996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT and SPECT/CT imaging of 90Y hepatic radioembolization at therapeutic and diagnostic activity levels: Anthropomorphic phantom study.
    Budzyńska A; Kubik A; Kacperski K; Pastusiak P; Kuć M; Piasecki P; Konior M; Gryziński M; Dziuk M; Iller E
    PLoS One; 2024; 19(2):e0271711. PubMed ID: 38421965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High quality imaging and dosimetry for yttrium-90 (
    Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.
    Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW
    Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Debebe SA; Adjouadi M; Gulec SA; Franquiz J; McGoron AJ
    J Appl Clin Med Phys; 2019 Feb; 20(2):30-42. PubMed ID: 30628156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatopulmonary Shunt Ratio Verification Model for Transarterial Radioembolization.
    Yeyin N; Kesmezacar FF; Tunçman D; Demir Ö; Uslu-Beşli L; Günay O; Demir M
    Curr Radiopharm; 2024; 17(3):276-284. PubMed ID: 38288829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculation of lung mean dose and quantification of error for
    Lopez B; Mahvash A; Lam MGEH; Kappadath SC
    Med Phys; 2019 Sep; 46(9):3929-3940. PubMed ID: 31063600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
    Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
    J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors modulating
    Lopez BP; Mahvash A; Long JP; Lam MGEH; Kappadath SC
    J Appl Clin Med Phys; 2022 Dec; 23(12):e13734. PubMed ID: 35906892
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Tabotta F; Gnesin S; Dunet V; Ponti A; Digklia A; Boughdad S; Schaefer N; Prior JO; Villard N; Tsoumakidou G; Denys A; Duran R
    Sci Rep; 2023 Aug; 13(1):13118. PubMed ID: 37573346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres.
    Elschot M; Nijsen JF; Lam MG; Smits ML; Prince JF; Viergever MA; van den Bosch MA; Zonnenberg BA; de Jong HW
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1965-75. PubMed ID: 24819055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing
    Noipinit N; Sukprakun C; Siricharoen P; Khamwan K
    Ann Nucl Med; 2024 Mar; 38(3):210-218. PubMed ID: 38142421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ-level internal dosimetry for intra-hepatic-arterial administration of
    Kappadath SC; Lopez BP
    Med Phys; 2022 Aug; 49(8):5504-5512. PubMed ID: 35612924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPECT and CT misregistration reduction in [
    Lu Z; Chen G; Jiang H; Sun J; Lin KH; Mok GSP
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2319-2330. PubMed ID: 36877236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
    Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
    J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative comparison of pre-therapy
    Knešaurek K; Tuli A; Pasik SD; Heiba S; Kostakoglu L
    Eur J Radiol; 2018 Dec; 109():57-61. PubMed ID: 30527312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of
    Allred JD; Niedbala J; Mikell JK; Owen D; Frey KA; Dewaraja YK
    EJNMMI Res; 2018 Jun; 8(1):50. PubMed ID: 29904808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic
    Struycken L; Patel M; Kuo P; Hennemeyer C; Woodhead G; McGregor H
    AJR Am J Roentgenol; 2022 Apr; 218(4):728-737. PubMed ID: 34704460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.